Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

High-dose treatment with the therapy was found to cause a 3.3% overall improvement in left ventricular ejection fraction.

Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...

EBR Systems is super confident the US medical gatekeeper will approve Wise, the world's first wireless pacemaker device. ...

Fresh research details a method than can detect congestive heart failure (CHF) using smartwatch ECG data with an impressive ...

Amavita has started using AISAP’s AI-powered POCUS diagnostic in community settings for aortic stenosis screening.

Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...

There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...

Cumberland Pharmaceuticals' Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients.

From there, blood flows across the tricuspid valve into the right ventricle, where it is sent to collect oxygen in the lungs. The electrical system of the heart is a complex system of specialized ...

The severity of left ventricular diastolic dysfunction affects risk for incident stroke and transient ischemic attack, as well as major bleeding.

由于其高患病率和发病率，心力衰竭（HF）仍然是对患者和医疗专业人员构成重大威胁的疾病。以下是 European Heart Journal（EHJ）整理的 2024 年发布的心衰领域 10 篇具有重大影响的研究。